Skip to main content
Clinical Trials/NCT05596279
NCT05596279
Completed
Not Applicable

Clinical Performance of a Novel Hybrid Intravascular Ultrasound-Optical Coherence Tomography System: a Prospective Randomized Controlled Clinical Trial

Harbin Medical University3 sites in 1 country100 target enrollmentNovember 20, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Harbin Medical University
Enrollment
100
Locations
3
Primary Endpoint
Clear stent capture rate (CSCR)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) were all recommended for percutaneous coronary intervention (PCI) optimization in the latest guidelines, however, which imaging modality was more suitable as either a diagnostic or guidance tool was still unknown. Recently, a novel, well-designed hybrid imaging system was approved for clinical use, allowing the accurate co-registration of two imaging modalities and immediate, simultaneous image review. For testing each modality in the hybrid imaging system, the investigators conducted this prospective, multicentre, non-inferiority trial. In this study, all participants achieved hybrid IVUS-OCT imaging after stenting, at meanwhile, patients randomly assigned to the IVUS arm were performed control IVUS (OptiCross, Boston Scientific, Natick, MA), and patients randomly assigned to the OCT arm were performed control OCT (C7 Dragonfly Duo, St. Jude Medical, St. Paul, MN). In this study, the investigators evaluated the non-inferiority of standalone IVUS versus control IVUS or standalone OCT versus control OCT in clinical feasibility using clear stent capture rate (CSCR) and safety using perioperative device-related adverse cardiovascular events.

Registry
clinicaltrials.gov
Start Date
November 20, 2019
End Date
July 30, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Harbin Medical University
Responsible Party
Principal Investigator
Principal Investigator

Yu Bo

Director of Department of Cardiology

The Second Affiliated Hospital of Harbin Medical University

Eligibility Criteria

Inclusion Criteria

  • Age 18-75 years
  • Patients eligible for elective percutaneous coronary intervention
  • Understand and voluntarily sign the informed consent form

Exclusion Criteria

  • The lesion-related exclusion criteria:
  • More than 1 stent was planned to deploy in culprit lesion
  • In-stent restenosis
  • Bifurcation lesion with proposed double stent implantation
  • The length of the reference vessel segment proximal or distal to the lesion was less than 5mm
  • The length of the implanted stent was larger than 33mm
  • The diameter of reference vessel was less than 2 mm or larger than 4 mm
  • Lesions were in left main or ostium of right coronary artery
  • The distance between either end of the lesion and the lateral branches larger than 2 mm in diameter was less than 5 mm
  • Angiography revealed thrombosis in culprit vessel

Outcomes

Primary Outcomes

Clear stent capture rate (CSCR)

Time Frame: During the procedure

The CSCR detected was defined as the ratio of the clear stent length to the total stent length

Secondary Outcomes

  • Detection rate of edge dissection, tissue prolapse and stent malapposition(During the procedure)
  • Device success rate(During the procedure)
  • Adverse procedure-related adverse cardiovascular events(Periprocedure)
  • Proportion of patients with clear image length ≥ 24mm(During the procedure)

Study Sites (3)

Loading locations...

Similar Trials